CIK: 1431443 - Address: C/o Clarus Ventures,, 101 Main Street, Suite 1210, Cambridge, MA 02142
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret4115-3-8-1512-140-5
S%wins67678040674561

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/22/19 16:30
3/22/19
NSTGNanostring Technologies IncDEFinancInvAdvInvestment AdviceClarus Lifesciences Ii, L.P.MATS-43,24021.620-2,000-502,036I
9/19/18 16:46
9/17/18
NSTGNanostring Technologies IncDEHealthBioPrdBiological Products, (No DiagClarus Lifesciences Ii, L.P.MATS.d-1,37215.990-86-24,036D
2/10/16 14:33
2/8/16
TLOGTetralogic Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-560.16930-334-132,215D-98-97-94-92-89-44-4060036553
2/5/16 20:39
2/3/16
TLOGTetralogic Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-2490.17590-1,415-362,548D-98-97-94-92-90-52-52-28-18-389539
2/2/16 17:12
1/29/16
TLOGTetralogic Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-720.19430-369-93,964D-98-96-92-89-86-36-33-25-43-215737
1/28/16 17:07
1/26/16
TLOGTetralogic Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-860.27561-312-74,333D-97-95-89-87-81-85-7-12-3-42-5746-15
1/12/15 09:44
1/8/15
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagClarus Lifesciences Ii, L.P.MATS-5,44431.118-175-53,324D51164812040-2-2-816-38-39
1/6/15 15:41
1/5/15
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagClarus Lifesciences Ii, L.P.MATS-72930.867-24-13,499D711748201631-1-155-40-25
12/30/14 10:09
12/26/14
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagClarus Lifesciences Ii, L.P.MATS.m-2,42630.058-81-23,523D73214325006-31-84-41-21
12/24/14 15:10
12/22/14
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagClarus Lifesciences Ii, L.P.MATS.m-1,50930.3611-50-13,604D6655514-1-5-64368-35-15
6/11/14 19:45
6/9/14
OPHTOphthotech Corp.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-9,61445.4227-212-72,848M482233139-11-6-10-10511
6/4/12 15:45
5/31/12
ACHNAchillion Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.d-9,8687.495-1,317-1110,942I170-74-33-17-4-1-91-7-3-5613
1/13/10 17:50
1/11/10
ACHNAchillion Pharmaceuticals IncHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS-8813.774-234-54,387I-271601218749-70-10-6-10-168-1742
1/8/10 17:31
1/6/10
ACHNAchillion Pharmaceuticals IncHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-1863.503-53-14,621I-1931815195859911-10-16-28-11-2922
12/29/09 17:17
12/24/09
ACHNAchillion Pharmaceuticals IncHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS-133.533-404,674I-2526112784664100-41-25-13-3021
12/23/09 17:50
12/21/09
ACHNAchillion Pharmaceuticals IncHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-1,0493.692-284-64,677I-3126613784884451-9-5-15-39-28-393
12/18/09 18:32
12/16/09
ACHNAchillion Pharmaceuticals IncHealthDrugPharmaceutical PreparationsClarus Lifesciences Ii, L.P.MATS.m-7303.532-207-44,961I-282541698412086596732-16-14-29-7

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact